Spero Therapeutics, Inc.
SPRO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $49 | $31 | $49 | $53 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $24 | $24 | $52 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $4 | $2 | $2 |
| Total Curr. Assets | $52 | $59 | $75 | $107 |
| Property Plant & Equip (Net) | $2 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $3 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $54 | $62 | $78 | $111 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $2 | $7 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $0 | $17 | $22 |
| Other Curr. Liab. | $8 | $12 | $8 | $18 |
| Total Curr. Liab. | $14 | $15 | $29 | $49 |
| LT Debt | $1 | $2 | $2 | $3 |
| Deferred Rev, NC | $0 | $0 | $13 | $12 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $13 | $13 | $0 | $1 |
| Total NC Liab. | $14 | $14 | $15 | $15 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $4 | $2 | $4 |
| Total Liabilities | $28 | $29 | $44 | $64 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$483 | -$475 | -$474 | -$460 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $509 | $508 | $507 | $506 |
| Total Equity | $26 | $33 | $34 | $46 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $54 | $62 | $78 | $111 |
| Net Debt | -$45 | -$28 | -$45 | -$49 |